Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc.

EBS | NYSE
Chart Builder DCF Calculator
$6.55
-$0.25 (-3.68%)
At close: Sep 21, 2026, 4:00 PM ET
$6.55
$0 (0.00%)
After-hours: Sep 21, 2026, 4:18 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
205.4M 99.5M 111.7M 642.6M 576.3M 621.3M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
14.2M 18.9M 178.1M 171.9M 29.9M 82.4M
Receivables
84.2M 154.5M 191M 159.2M 278.9M 230.9M
Inventory
343.4M 311.7M 328.9M 350.7M 344.5M 307M
Other Current Assets
29.5M 33M 47.9M 57.9M 70.2M 2.2M
Total Current Assets
662.5M 598.7M 679.5M 1.21B 1.27B 1.2B
Property-Plant & Equipment
205.4M 270.6M 399M 837M 828.4M 675.1M
Goodwill & Intangibles
436.5M 501.5M 566.6M 947M 829.5M 929.8M
Total Long-Term Assets
656.1M 791M 1.14B 1.96B 1.69B 1.69B
Total Assets
1.32B 1.39B 1.82B 3.17B 2.96B 2.88B
Account Payables
55.6M 60.9M 112.2M 103.5M 128.9M 136.1M
Deferred Revenue
n/a n/a n/a 26.4M 11.7M n/a
Short-Term Debt
n/a 2.7M 413.7M 963.1M 37.4M 39.5M
Other Current Liabilities
76.6M 81.1M 106.8M 48.6M 107.3M 72M
Total Current Liabilities
132.2M 162.4M 651.3M 1.23B 374M 384.5M
Long-Term Debt
572.1M 663.7M 446.5M 448.5M 809.4M 850.3M
Other Long-Term Liabilities
53.9M 29.4M 28.9M 26.7M 40.6M 173.6M
Total Long-Term Liabilities
663.8M 744.5M 522.6M 549.7M 972.2M 1.05B
Total Liabilities
796M 906.9M 1.17B 1.78B 1.35B 1.44B
Total Debt
572.1M 676.1M 860.2M 1.43B 871M 923M
Book Value
522.6M 482.8M 649.3M 1.39B 1.61B 1.45B
Book Value Per Share
9.22 9.11 12.68 27.70 29.79 26.90
Common Stock
100K 100K 100K 100K 100K 100K
Retained Earnings
-159.8M -212.4M -21.8M 738.7M 950.3M 726.9M
Comprehensive Income
-7.5M -5.2M -5.7M 3.1M -16.1M -25.3M
Shareholders Equity
522.6M 482.8M 649.3M 1.39B 1.61B 1.45B
Total Investments
n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.